Avery LaChance

935 total citations
66 papers, 471 citations indexed

About

Avery LaChance is a scholar working on Dermatology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Avery LaChance has authored 66 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Dermatology, 16 papers in Pathology and Forensic Medicine and 15 papers in Rheumatology. Recurrent topics in Avery LaChance's work include Systemic Sclerosis and Related Diseases (12 papers), Inflammatory Myopathies and Dermatomyositis (11 papers) and Autoimmune Bullous Skin Diseases (10 papers). Avery LaChance is often cited by papers focused on Systemic Sclerosis and Related Diseases (12 papers), Inflammatory Myopathies and Dermatomyositis (11 papers) and Autoimmune Bullous Skin Diseases (10 papers). Avery LaChance collaborates with scholars based in United States, Puerto Rico and Argentina. Avery LaChance's co-authors include Bina Kassamali, Ruth Ann Vleugels, Daniel R. Mazori, Gabriela Cobos, Michelle S. Min, Guohai Zhou, Alice J. Tan, Mehdi Rashighi, Steven K. Krueger and Neda Shahriari and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of Investigative Dermatology.

In The Last Decade

Avery LaChance

54 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avery LaChance United States 10 133 87 87 70 65 66 471
Christopher N. Graham United States 16 123 0.9× 69 0.8× 96 1.1× 41 0.6× 77 1.2× 45 576
Melanie Hagen Germany 9 97 0.7× 36 0.4× 167 1.9× 46 0.7× 82 1.3× 33 482
Heather A. Brandling‐Bennett United States 13 36 0.3× 99 1.1× 48 0.6× 53 0.8× 53 0.8× 43 492
Lara Valeska Maul Switzerland 12 101 0.8× 108 1.2× 32 0.4× 81 1.2× 74 1.1× 49 537
Orhan Zengin Türkiye 14 47 0.4× 41 0.5× 103 1.2× 53 0.8× 124 1.9× 30 499
Anne Howard Australia 13 32 0.2× 128 1.5× 65 0.7× 107 1.5× 73 1.1× 31 436
Rafał Białynicki‐Birula Poland 11 53 0.4× 152 1.7× 73 0.8× 36 0.5× 15 0.2× 38 444
Viviana Lora Italy 17 242 1.8× 304 3.5× 106 1.2× 113 1.6× 51 0.8× 42 725
Melanie Weiß Germany 12 45 0.3× 114 1.3× 30 0.3× 72 1.0× 13 0.2× 21 596
Deepti Gupta United States 14 80 0.6× 146 1.7× 20 0.2× 104 1.5× 31 0.5× 32 640

Countries citing papers authored by Avery LaChance

Since Specialization
Citations

This map shows the geographic impact of Avery LaChance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avery LaChance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avery LaChance more than expected).

Fields of papers citing papers by Avery LaChance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avery LaChance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avery LaChance. The network helps show where Avery LaChance may publish in the future.

Co-authorship network of co-authors of Avery LaChance

This figure shows the co-authorship network connecting the top 25 collaborators of Avery LaChance. A scholar is included among the top collaborators of Avery LaChance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avery LaChance. Avery LaChance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LaChance, Avery, et al.. (2025). Artificial intelligence for autoimmune diseases. npj Digital Medicine. 8(1). 628–628.
2.
Kim, Yoo Jung, Neda Shahriari, Avery LaChance, et al.. (2025). Improvement in dermatomyositis-associated muscle disease with anifrolumab. British Journal of Dermatology. 192(6). 1126–1128. 6 indexed citations
3.
Sparks, Jeffrey A., et al.. (2025). Distinct Cancer Risk Profiles in Patients With Systemic Sclerosis With Autoantibody Stratification. Arthritis & Rheumatology. 78(3). 705–712.
4.
LaChance, Avery, et al.. (2025). Autoantibody testing practices and clinical implications in morphea: A 5-year multicenter retrospective study. Journal of the American Academy of Dermatology. 94(2). 585–588.
5.
Shahriari, Neda, Daniel R. Mazori, Mona Shahriari, et al.. (2023). Utility of magnetic resonance imaging in the diagnosis of eosinophilic fasciitis: A multicenter retrospective cohort study. Journal of the American Academy of Dermatology. 89(6). 1313–1315. 3 indexed citations
6.
Nambudiri, Vinod E., et al.. (2023). Trends in dermatology telehealth uptake in Medicare beneficiaries from 2010 to 2020: A retrospective cross-sectional analysis. Journal of the American Academy of Dermatology. 88(5). 1214–1215.
7.
Shaw, Katharina S., C. Pan, Neda Shahriari, et al.. (2023). Clinical characteristics of palmoplantar discoid lupus erythematosus: A multicenter retrospective review of 43 patients. SHILAP Revista de lepidopterología. 2(3). 566–570. 1 indexed citations
8.
Han, Jane, Priya Manjaly, Karen J. Lee, et al.. (2022). Physician values in alopecia areata treatment decision-making: A qualitative assessment. JAAD International. 11. 14–23.
9.
Nambudiri, Vinod E., et al.. (2022). The Resident Physician Shortage Reduction Act: An opportunity to address the rural dermatology workforce deficit. Journal of the American Academy of Dermatology. 87(6). 1461–1464. 1 indexed citations
10.
Kassamali, Bina, Kylee J.B. Kus, Michelle S. Min, et al.. (2021). Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients. JAAD International. 3. 111–114. 3 indexed citations
11.
Tan, Alice J., Bina Kassamali, Guohai Zhou, et al.. (2021). The Impact of Telehealth Implementation on Underserved Populations and No-Show Rates by Medical Specialty During the COVID-19 Pandemic. Telemedicine Journal and e-Health. 27(8). 874–880. 67 indexed citations
12.
Kassamali, Bina, et al.. (2021). 281 Racial and language disparities in teledermatology visits for acne during the COVID-19 pandemic. Journal of Investigative Dermatology. 141(5). S50–S50. 1 indexed citations
13.
Min, Michelle S., Bina Kassamali, Daniel R. Mazori, et al.. (2021). Lack of association between tumor necrosis factor-α inhibitor use and exacerbation of lupus erythematosus: A retrospective cohort study. Journal of the American Academy of Dermatology. 86(5). 1180–1182.
14.
Lee, Michelle S., Bina Kassamali, Nidhi Shah, Avery LaChance, & Vinod E. Nambudiri. (2021). Differences in virtual care utilization for acne by vulnerable populations during the COVID-19 pandemic: A retrospective review. Journal of the American Academy of Dermatology. 85(3). 718–719. 5 indexed citations
15.
Lo, Kelly, et al.. (2021). Challenges of securing insurance approval for oral tofacitinib for the treatment of alopecia areata: a multi-institution retrospective review. Archives of Dermatological Research. 314(5). 487–489. 5 indexed citations
16.
Kassamali, Bina, et al.. (2021). A case of paradoxical fibrosis and development of morphea in a patient on dupilumab. JAAD Case Reports. 17. 7–8. 6 indexed citations
17.
Feng, Jessica, Avery LaChance, David Sinclair, & Maryam M. Asgari. (2019). Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1. BMJ Case Reports. 12(3). e227233–e227233. 3 indexed citations
18.
Sreih, Antoine G., Rana Ezzeddine, Lin Leng, et al.. (2011). Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis & Rheumatism. 63(12). 3942–3951. 91 indexed citations
19.
Down, J. D., Michel Awwad, Kathleen Moran, et al.. (2000). Increases in autologous hematopoietic progenitors in the blood of baboons following irradiation and treatment with porcine stem cell factor and interleukin-3. Transplantation Proceedings. 32(5). 1045–1046. 3 indexed citations
20.
LaChance, Avery, et al.. (1998). The sands of the Sahara.. PubMed. 33(7). 387–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher N. Graham Breakdown of academic impact, for papers by Melanie Hagen Breakdown of academic impact, for papers by Heather A. Brandling‐Bennett Breakdown of academic impact, for papers by Lara Valeska Maul Breakdown of academic impact, for papers by Orhan Zengin Breakdown of academic impact, for papers by Anne Howard Breakdown of academic impact, for papers by Rafał Białynicki‐Birula Breakdown of academic impact, for papers by Viviana Lora Breakdown of academic impact, for papers by Melanie Weiß Breakdown of academic impact, for papers by Deepti Gupta
Rankless by CCL
2026